Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
- PMID: 17603494
- DOI: 10.1038/nm1605
Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
Abstract
Psoriasis is a common T cell-mediated autoimmune inflammatory disease. We show that blocking the interaction of alpha1beta1 integrin (VLA-1) with collagen prevented accumulation of epidermal T cells and immunopathology of psoriasis. Alpha1beta1 integrin, a major collagen-binding surface receptor, was exclusively expressed by epidermal but not dermal T cells. Alpha1beta1-positive T cells showed characteristic surface markers of effector memory cells and contained high levels of interferon-gamma but not interleukin-4. Blockade of alpha1beta1 inhibited migration of T cells into the epidermis in a clinically relevant xenotransplantation model. This was paralleled by a complete inhibition of psoriasis development, comparable to that caused by tumor necrosis factor-alpha blockers. These results define a crucial role for alpha1beta1 in controlling the accumulation of epidermal type 1 polarized effector memory T cells in a common human immunopathology and provide the basis for new strategies in psoriasis treatment focusing on T cell-extracellular matrix interactions.
Comment in
-
The problem with upward mobility.Nat Med. 2007 Jul;13(7):786-7. doi: 10.1038/nm0707-786. Nat Med. 2007. PMID: 17618268 No abstract available.
Similar articles
-
Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin.Nature. 2007 Apr 5;446(7136):680-4. doi: 10.1038/nature05652. Epub 2007 Mar 21. Nature. 2007. PMID: 17377534
-
The role of very late antigen-1 in immune-mediated inflammation.Clin Immunol. 2004 Nov;113(2):119-29. doi: 10.1016/j.clim.2004.06.007. Clin Immunol. 2004. PMID: 15451466 Review.
-
Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1917-24. doi: 10.1161/01.ATV.0000174807.90292.2f. Epub 2005 Jun 23. Arterioscler Thromb Vasc Biol. 2005. PMID: 15976328
-
Very late antigen-1 in psoriasis: an immunohistochemical study.J Eur Acad Dermatol Venereol. 2008 Mar;22(3):283-9. doi: 10.1111/j.1468-3083.2007.02402.x. J Eur Acad Dermatol Venereol. 2008. PMID: 18269595
-
Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.Clin Dermatol. 2007 Nov-Dec;25(6):581-8. doi: 10.1016/j.clindermatol.2007.08.013. Clin Dermatol. 2007. PMID: 18021896 Review.
Cited by
-
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity.Cell Commun Signal. 2024 Nov 8;22(1):536. doi: 10.1186/s12964-024-01924-z. Cell Commun Signal. 2024. PMID: 39516877 Free PMC article.
-
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory.Int J Mol Sci. 2024 May 31;25(11):6086. doi: 10.3390/ijms25116086. Int J Mol Sci. 2024. PMID: 38892277 Free PMC article.
-
The Immunology of Psoriasis-Current Concepts in Pathogenesis.Clin Rev Allergy Immunol. 2024 Apr;66(2):164-191. doi: 10.1007/s12016-024-08991-7. Epub 2024 Apr 20. Clin Rev Allergy Immunol. 2024. PMID: 38642273 Free PMC article. Review.
-
Integrins in Health and Disease-Suitable Targets for Treatment?Cells. 2024 Jan 23;13(3):212. doi: 10.3390/cells13030212. Cells. 2024. PMID: 38334604 Free PMC article. Review.
-
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis.Front Immunol. 2023 Sep 20;14:1212981. doi: 10.3389/fimmu.2023.1212981. eCollection 2023. Front Immunol. 2023. PMID: 37809085 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
